# Phase 6 decision record

## Decision metadata

- **Phase:** 6 — Decision Synthesis & Recommendation
- **Starting commit:** `92e0e7e5c87284d49a79a6a481e978637026fa8f`
- **Decision classification:** **PASS_WITH_STAKEHOLDER_HOLD**
- **Stakeholder gate:** `G8 = NOT_YET_VALIDATED`
- **Decision scope:** Analytical and technical priority only; no implementation, collection, published-data change, merge, PR, or portfolio release.

## Phase objective

Convert the existing bounded evidence, requirements, analytics, governed publication, product implementation, Power BI validation, and QA record into an auditable recommendation for what PULSE should prioritize next to improve decision usefulness without weakening evidence standards.

## Evidence reviewed

The decision used:

- project context, README, Phase 2 collection/history/sufficiency/detector/closure records, and machine-readable validation summary;
- Phase 3 root-cause, capability, gap, workflow, requirements, business rules, acceptance, stakeholder gate, closure, and public PR secondary-research records;
- Phase 4 analytical architecture, metric registry/contracts, M2 metric results, M3 product analysis, M4.1/M4.1B replay/publication, and M4.2 Power BI implementation/validation/reconciliation;
- Phase 5 M5.4 integration findings, acceptance results, traceability, UX friction, synthesis inputs, and portfolio evidence inventory.

The governed baseline is two published investigations, eight declared members, 40 findings (38 UNKNOWN, two bounded NO, zero positive), two inherited rejected candidates from one shared artifact, and historical context of one PAIRED, six AFTER_ONLY, and nine UNRESOLVED records. The public PR sample remains a separate secondary-research population.

## Alternatives considered

1. **A — Evidence depth first:** directly addresses question/source and historical sufficiency gaps, but could become open-ended without gates.
2. **B — Cohort breadth first:** adds cases with the current method; risks scaling uncertainty and misleading counts.
3. **C — Investigator workflow first:** could improve review/explanation, but the technical read workflow already exists and user/reviewer value remains unvalidated.
4. **D — Sequenced/gated:** evidence depth first, then authorized source and stakeholder/workflow validation, then selective breadth.

The comparison used qualitative criteria: evidence sufficiency, decision usefulness, provenance, analytical validity, effort, technical and governance risk, reproducibility, architecture fit, incremental validation, stakeholder dependency, and demonstrability. No arbitrary weighted score was created.

## Chosen recommendation

Choose **D — sequenced/gated**, with **A — evidence depth first** as the only immediate investment. Freeze a bounded experiment; test historical depth, explicit source availability, question-specific prerequisites/reasons, and support linkage; compare method versions without changing published evidence; progress only when a named gate passes.

## Rejected or deferred alternatives

- **B is deferred** because collection breadth does not repair missing qualifying inputs and could multiply UNKNOWN findings.
- **C is deferred** because reviewer authority, workflow value, and acceptable burden are stakeholder-dependent; active writes also require a legitimate DRAFT case.
- **A without gates is rejected** because it could encourage unbounded source accumulation. A is retained inside D with stop criteria.
- Production scaling, portfolio scoring, AI/ML, broad source harvesting, new dashboards, and final portfolio packaging are outside the recommendation.

## Major uncertainties

- Whether deeper public history can increase valid paired context.
- Whether resolved-version or recovery evidence is accessible and relevant.
- Whether a real decision owner values the bounded question and honest UNKNOWN result.
- Which source and completion thresholds are acceptable.
- Whether an authorized reviewer and representative DRAFT case exist.
- Whether the method transfers beyond the two validation cases.

These uncertainties are not resolved by technical completeness.

## Stakeholder dependency

No stakeholder response, approval, validated persona, demand, workflow value, review burden, ROI, or completion definition is recorded. Phase 6 does not require stakeholder validation for its bounded analytical recommendation, but any workflow, product-value, source-threshold, or production-investment decision remains on hold.

## Acceptance result

| Phase 6 criterion | Result | Evidence |
| --- | --- | --- |
| Evidence-backed current state | PASS | [Current-state assessment](current-state-assessment.md) |
| Collection completeness distinct from analytical sufficiency | PASS | [Capability-gap analysis](capability-gap-analysis.md) |
| Root causes and capability gaps explicit | PASS | Issue tree and ten gap classes |
| Four credible alternatives and tradeoffs | PASS | [Alternatives analysis](alternatives-analysis.md) |
| One bounded recommendation | PASS | [Recommendation](recommendation.md) |
| Recommendation traceability | PASS | [Traceability](recommendation-traceability.md) |
| Roadmap follows recommendation | PASS | [Roadmap](roadmap.md) |
| Proposed measure semantics complete | PASS | [Proposed measures](proposed-success-measures.md) |
| Risks, assumptions, dependencies explicit | PASS | [RAD register](risks-assumptions-dependencies.md) |
| Stakeholder validation remains pending | PASS | G8 `NOT_YET_VALIDATED` throughout |
| No unsupported adoption/recovery/value claim | PASS | Claim audit and traceability exclusions |
| No new technical subsystem | PASS | Documentation-only Phase 6 |

## Decision

**PASS_WITH_STAKEHOLDER_HOLD.** Phase 6 produces a complete, evidence-bounded recommendation and audit trail. It does not authorize implementation or indicate that stakeholder-dependent product questions are resolved.

## Next gate

The next recommended milestone is a separately authorized **Evidence Depth Validation** milestone implementing only the NOW horizon in the [roadmap](roadmap.md). Before work begins, it must freeze the experiment question, population, source policy, method comparison, success/stop criteria, and publication boundary. Final Portfolio Release remains out of scope until that milestone decision and any required consulting closure are complete.
